Lazarus J H, John R, Ginsberg J, Hughes I A, Shewring G, Smith B R, Woodhead J S, Hall R
Br Med J (Clin Res Ed). 1983 Feb 19;286(6365):592-4. doi: 10.1136/bmj.286.6365.592.
In a screening programme for neonatal hypothyroidism an otherwise healthy female infant was found to have a high concentration of thyroid stimulating hormone in a filter paper blood spot and in serum. A high concentration was also found in the maternal serum. Mother and baby were both biochemically euthyroid with normal serum thyroxine concentrations. The apparently high concentration of thyroid stimulating hormone in the mother was due to the presence of an IgG antibody that bound to human but not bovine thyroid stimulating hormone. Maternal serum inhibited the action of human thyroid stimulating hormone in an in vitro bioassay for the hormone. It is suggested that the baby acquired the antibody transplacentally, especially as the concentration of thyroid stimulating hormone subsequently fell. It is concluded that maternal serum should be assayed for thyroid stimulating hormone when a neonate is found to have a high concentration of the hormone and a normal concentration of thyroxine to establish the incidence of this finding and to avoid inappropriate replacement treatment.
在一项新生儿甲状腺功能减退筛查项目中,一名原本健康的女婴在滤纸血斑和血清中被发现促甲状腺激素浓度较高。在母亲血清中也发现了高浓度。母亲和婴儿的甲状腺功能均生化正常,血清甲状腺素浓度正常。母亲促甲状腺激素明显高浓度是由于存在一种与人类促甲状腺激素而非牛促甲状腺激素结合的IgG抗体。在该激素的体外生物测定中,母亲血清抑制了人类促甲状腺激素的作用。提示婴儿经胎盘获得了该抗体,尤其是促甲状腺激素浓度随后下降。结论是,当新生儿促甲状腺激素浓度高而甲状腺素浓度正常时,应检测母亲血清中的促甲状腺激素,以确定这一发现的发生率并避免不适当的替代治疗。